Literature DB >> 16473278

Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.

Brian B Haines1, Chun Jeih Ryu, Sandy Chang, Alexei Protopopov, Andreas Luch, Yun Hee Kang, Dobrin D Draganov, Maria F Fragoso, Sang Gi Paik, Hyo Jeong Hong, Ronald A DePinho, Jianzhu Chen.   

Abstract

Mice deficient in the DNA damage sensor P53 display normal T cell development but eventually succumb to thymic lymphomas. Here, we show that inactivation of the TCR beta gene enhancer (E beta) results in a block of T cell development at stages where recombination-activating genes (RAG) are expressed. Introduction of the E beta mutation into p53-/- mice dramatically accelerates the onset of lethal thymic lymphomas that harbor RAG-dependent aberrant rearrangements, chromosome 14 and 12 translocations, and amplification of the chromosomal region 9A1-A5.3. Phenotypic and genetic analyses suggest that lymphomas emerge through a normal thymocyte development pathway. These findings provide genetic evidence that block of lymphocyte development at stages with RAG endonuclease activity can provoke lymphomagenesis on a background with deficient DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473278     DOI: 10.1016/j.ccr.2006.01.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  18 in total

1.  IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis.

Authors:  R Kibe; S Zhang; D Guo; L Marrero; F Tsien; P Rodriguez; S Khan; A Zieske; J Huang; W Li; S K Durum; T Iwakuma; Y Cui
Journal:  Cell Death Differ       Date:  2012-01-27       Impact factor: 15.828

2.  SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability.

Authors:  Y Wang; S Klumpp; H M Amin; H Liang; J Li; Z Estrov; P Zweidler-McKay; S J Brandt; A Agulnick; L Nagarajan
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

3.  Identification of the transgenic integration site in 2C T cell receptor transgenic mice.

Authors:  Chae-Yeon Son; Brian B Haines; Andreas Luch; Chun Jeih Ryu
Journal:  Transgenic Res       Date:  2018-08-21       Impact factor: 2.788

4.  Coupling of V(D)J recombination to the cell cycle suppresses genomic instability and lymphoid tumorigenesis.

Authors:  Li Zhang; Taylor L Reynolds; Xiaochuan Shan; Stephen Desiderio
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

5.  p53 Hinders CRISPR/Cas9-Mediated Targeted Gene Disruption in Memory CD8 T Cells In Vivo.

Authors:  Samarchith P Kurup; Steven J Moioffer; Lecia L Pewe; John T Harty
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

6.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

7.  Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis.

Authors:  W Hanel; N Marchenko; S Xu; S Xiaofeng Yu; W Weng; U Moll
Journal:  Cell Death Differ       Date:  2013-03-29       Impact factor: 15.828

8.  Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.

Authors:  Mai Xu; Qing Yu; Ramesh Subrahmanyam; Michael J Difilippantonio; Thomas Ried; Jyoti Misra Sen
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

9.  Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice.

Authors:  Yasushi Kawasaki; Yoko Hirabayashi; Toyozo Kaneko; Jun Kanno; Yukio Kodama; Yuuko Matsushima; Yukio Ogawa; Minoru Saitoh; Kiyoshi Sekita; Osayuki Uchida; Takashi Umemura; Byung-Il Yoon; Tohru Inoue
Journal:  Toxicol Sci       Date:  2009-05-28       Impact factor: 4.849

10.  Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.

Authors:  William Giblin; Monalisa Chatterji; Gerwin Westfield; Tehmina Masud; Brian Theisen; Hwei-Ling Cheng; Jeffrey DeVido; Frederick W Alt; David O Ferguson; David G Schatz; JoAnn Sekiguchi
Journal:  Blood       Date:  2009-01-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.